Heart Disease Clinical Trials in Cleveland

Showing 301-320 of 521 trials

Randomized Study of Organ Care System Cardiac for Preservation of Donated Hearts for Eventual Transplantation

NCT00855712

The purpose of the study is to compare survival of both patients and newly transplanted hearts following heart transplantation among patients who were transplanted with donated hearts preserved on ice and those who were transplanted with donated hearts using the Organ Care System (OCS). The Organ care system preserves the hearts in a warm blood perfused beating state. The study also compares the number of rejection episodes, heart related adverse events, ICU time, and ventilation time between the two groups. The study is considered a success if survival in the OCS group was not inferior to the ice group.

Heart Failure

TransMedics128 participantsStarted Mar 2009

Los Angeles, California, United States • Los Angeles, California, United States • Indianapolis, Indiana, United States +8 more locations

COMPLETED< 1 mile

VITROS Immunodiagnostic Products NT-proBNP II

NCT03548909

Amino Terminal pro-Brain Natriuretic Peptide (NTproBNP) is secreted in conditions of cardiac wall stress. NTproBNP levels are used in addition to clinical assessment to diagnose heart failure (HF). The purpose of this clinical study is to collect data to substantiate the use of the VITROS NT-proBNP II assay.

Heart Failure

Ortho-Clinical Diagnostics, Inc.3,246 participantsStarted Jun 2018

Montgomery, Alabama, United States • Tucson, Arizona, United States • Beverly Hills, California, United States +22 more locations

Randomized Study of Organ Care System Cardiac for Preservation of Donated Hearts for Eventual Transplantation

VITROS Immunodiagnostic Products NT-proBNP II

Heart Disease Trials in Other Cities

A Study of RO4607381 in Stable Coronary Heart Disease Patients With Recent Acute Coronary Syndrome

Virtual Visits in Heart Failure Care Transitions

Evaluation of Long-Term Safety and Tolerability of ETC-1002 in High-Risk Patients With Hyperlipidemia and High CV Risk (CLEAR Harmony)

Mitroflow DL Post Approval Study- North America

Evaluation of the Efficacy and Safety of Bempedoic Acid (ETC-1002) in Patients With Hyperlipidemia and Statin Intolerant

A Study of the Effect of Dalcetrapib on Artherosclerotic Disease in Patients With Coronary Artery Disease

Evaluation of the Safety and Effectiveness of the DuraHeart™ LVAS

HW006 LATERAL Thoracotomy

Patient and Provider Assessment of Lipid Management Registry

A Study to Assess the Effect of Intravenous Dose of (aMBMC) to Subjects With Non-ischemic Heart Failure

Prasugrel for Prevention of Early Saphenous Vein Graft Thrombosis

A Study of VentriGel in Post-MI Patients

Integrated Tele-monitoring and Patient-centric Health Coaching Strategy in Patients Hospitalized With Heart Failure

Comparison of a Rivaroxaban-based Strategy With an Antiplatelet-based Strategy Following Successful TAVR for the Prevention of Leaflet Thickening and Reduced Leaflet Motion as Evaluated by Four-dimensional, Volume-rendered Computed Tomography (4DCT)

Self-Management App for Patients With Left-Ventricular Assist Devices

Functional Lesion Assessment of Intermediate Stenosis to Guide Revascularisation

ENABLE: CHF-PC (Comprehensive Heartcare For Patients and Caregivers)

e-NOBORI Observational Registry of Nobori DES

Other Conditions in Cleveland